Skip to search formSkip to main contentSkip to account menu

Ucb 11056

Known as: Ucb-11056 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation.
In vitro preformulation testing has shown that the solubility and dissolution rate of the model drug compound ucb 11056 are… 
1998
1998
Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. II. Bioavailability and tolerance assessment in dogs.
Sustained-release (SR) dosage forms consisting of pellets coated with different pH-sensitive film layers, previously optimized in… 
1993
1993
ucb 11056, a New Potential Nootropic Drug, Amplifies Induced Cyclic AMP Formation in Rat Brain Tissue
ucb 11056 [2‐(4‐morpholino‐6‐propyl‐1, 3, 5‐triazin‐2‐yl)aminoethanol] induced a significant (∼25%) increase in cyclic AMP levels… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)